DFCM
RGNX icon

Dark Forest Capital Management’s Regenxbio RGNX Stock Holding History

Dark Forest Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,984
Closed -$274K – 859
2024
Q1 		$274K Buy
+12,984
New +$231K 0.05% 500
2023
Q3 		– Sell
-26,655
Closed -$533K – 1280
2023
Q2 		$533K Buy
26,655
+13,914
+109% +$268K 0.05% 601
2023
Q1 		$241K Buy
+12,741
New +$282K 0.06% 312
2022
Q4 		– Sell
-2,437
Closed -$64K – 1436
2022
Q3 		$64K Buy
2,437
+2,428
+26,978% +$72K 0.01% 495
2022
Q2 		$0 Buy
+9
New +$225 ﹤0.01% 1299

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Dark Forest Capital Management's RGNX Position: Q2 2024 in Review

Dark Forest Capital Management sold out of Regenxbio (RGNX) in Q2 2024, closing a stake of 12,984 shares — an estimated $274K sold.

Dark Forest Capital Management first reported a position in RGNX in Q2 2022 and held it in 5 quarters. The position peaked at $533K in Q2 2023. 181 funds tracked by Wall St. Rank hold RGNX as of Q2 2024.

  • Dark Forest Capital Management reported no remaining Regenxbio position as of Q2 2024 after selling out during the quarter.
  • Dark Forest Capital Management sold 12,984 Regenxbio shares in Q2 2024, an estimated $274K.
  • Dark Forest Capital Management first reported a position in Regenxbio in Q2 2022 and held it in 5 quarters.
  • Dark Forest Capital Management's Regenxbio position peaked at $533K in Q2 2023.
  • 181 funds tracked by Wall St. Rank held Regenxbio as of Q2 2024.

Based on Dark Forest Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.